Overview

Subarachnoid Hemorrhage Recovery And Galantamine

Status:
Completed

Trial end date:
2019-07-20

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine the effects of the study drug--Galantamine-on patients with subarachnoid hemorrhage (SAH). The study will examine how patients with SAH will tolerate the study drug and how it may improve brain functioning in patients after SAH.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

The University of Texas Health Science Center, Houston

Treatments:

Galantamine